Should transdermal rather than oral estrogens be used in menopausal hormone therapy?: a review

Fournier, Agnè
March 2010
Menopause International;Mar2010, Vol. 16 Issue 1, p23
Academic Journal
The current evaluation of the benefit/risk ratio associated with menopausal hormone therapy (MHT) use is largely based on clinical trials which investigated the effects of oral treatments. Would MHT with transdermal estrogens be associated with a more favourable benefit/risk ratio? We reviewed the available epidemiologic evidence on that question. Epidemiologic studies were considered if they provided risk estimates of conditions which carry an important weight among menopausal women, and for which epidemiologic evidence of a possible link with MHT use is convincing: cardiovascular diseases, breast cancer, diabetes, colorectal cancer and hip fracture. We did not include studies with only surrogate measures. We found that the available information on the potential impact of the route of administration of MHT on the risk of our selected outcomes is limited. To date, epidemiologic data suggest that it has no impact on the risk of breast cancer and hip fracture. Results on the risk of coronary heart disease and colorectal cancer are inconsistent. Studies on stroke and diabetes risk are too few to allow meaningful conclusions. There is a suggestion that transdermal MHT may be less deleterious than oral MHT regarding venous thromboembolism which needs to be confirmed. The issue of the route of administration of MHT should remain an active area of research as part of an attempt to identify treatment modalities that would have the least potential for exerting adverse effects.


Related Articles

  • Should women reconsider hormones?  // Consumer Reports on Health;Dec2007, Vol. 19 Issue 12, p4 

    The article reports on the impact of the study which identifies the health risks brought about by hormone replacement therapy (HRT). It was reported that the identification of diseases acquired from the administration of HRT led many women to stop taking the hormone estrogen. The therapy...

  • Independent Nurse: Clinical - At a glance - Poikiloderma of Civatte.  // GP: General Practitioner;3/24/2006, p98 

    This article presents information on etiology and clinical features of the medical condition known as poikiloderma of civatte. It is common in middle-aged women on sun-exposed parts of the neck. Hormonal changes related to the menopause or low oestrogen levels have been implicated. The primary...

  • cool off. Ervolino, Frank // Better Nutrition;Sep2005, Vol. 67 Issue 9, p32 

    The article presents information on various medical problems and also presents some solutions to get relieve from them. In some women undergoing menopause, hot flashes may occur sometimes. While hormone replacement therapy (HRT) works well for many women because it elevates estrogen levels in...

  • Sleep and the menopause. Polo-Kantola, Päivi; Erkkola, Risto // Journal of the British Menopause Society;2004, Vol. 10 Issue 4, p145 

    Sleep problems and their consequences are a serious public health issue, imposing a substantial burden on the individual and society. Although sleep occupies one-third of our lives and can be considered to be an important subject, sleep medicine is a young speciality and problems are poorly...

  • Hot flushes: are there effective alternatives to estrogen? Sassarini, Jenifer; Lumsden, Mary Ann // Menopause International;Jul2010, Vol. 16 Issue 2, p81 

    Hot flushes are the most common indication for the prescription of hormone replacement therapy (HRT) since it is effective in over 80% of cases. In 1995, 37% of American women took HRT, principally for this purpose. However, over the last five years, publications such as those from the Women's...

  • Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. Tikk, K.; Sookthai, D.; Johnson, T.; Rinaldi, S.; Romieu, I.; Tjønneland, A.; Olsen, A.; Overvad, K.; Clavel-Chapelon, F.; Baglietto, L.; Boeing, H.; Trichopoulou, A.; Lagiou, P.; Trichopoulos, D.; Palli, D.; Pala, V.; Tumino, R.; Rosso, S.; Panico, S.; Agudo, A. // Annals of Oncology;Jul2014, Vol. 25 Issue 7, p1422 

    In our prospective study, higher levels of prolactin were associated with significant increase in the risk of breast cancer among postmenopausal women who used hormone replacement therapy (HRT) at blood donation, whereas no association was found for the non-users of HRT. Our study therefore...

  • Menstrual Cycle Disorders.  // New Harvard Guide to Women's Health;2004, p382 

    Presents a comprehensive women's health guide to menstrual cycle disorders. Etiologies of amenorrhea; Disorders that may account for short or scanty periods; Effect of estrogen replacement therapy on the menstrual cycle; Incidence of polymenorrhea in women.

  • HRT is most beneficial for women under 60. Salpeter, S. R.; Walsh, J. M. E.; Greyber, E.; Ormiston, T. M.; Salpeter, E. E. // BMJ: British Medical Journal (International Edition);1/1/2005, Vol. 330 Issue 7481, Preceding p1 

    Answers a question on the beneficial effect of hormone replacement therapy in young postmenopausal women. Research showing cardiovascular or cancer related death rates were not affected by HRT in women 60 and older; Assertion that estrogen replacement in women under 60 is associated with a net...

  • SHOULD YOU TAKE ESTROGEN? Perlmutter, C. // Prevention;Nov89, Vol. 41 Issue 11, p42 

    This article discusses the risks and benefits of undergoing hormone-replacement therapy (HRT) at menopause. Alternatives to HRT are also discussed. HRT usually involves a regular program of estrogen to replace the natural estrogen that wanes at menopause. Sometimes, another hormone, progesterone...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics